Penumbra, Inc. (PEN): Projected Sales Volume

PEN (Penumbra Corp) - company brandmark

Penumbra, Inc. sales volume forecasts confirm a steady cash flow from regular thrombectomy procedures. High clinic loyalty to specialized neurovascular systems supports the trend, although technological breakthroughs by industry behemoths pose risks. The current parameter is 2.33, demonstrating strong growth dynamics in the commercial indicators of Penumbra, Inc. amid high operational momentum.

PEN - Penumbra Medical Company Revenue Forecast over the range 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Penumbra Corp (PEN)

- stock value and consensus price forecast:
Comprehensive company analysis:PEN Penumbra
Brand item of Penumbra Inc

Penumbra, Inc. (PEN) production of neurovascular catheters ensures stable demand regardless of economic cycles, making the company's future sales trajectory a reliable indicator of fundamental stability. This metric aggregates analysts' consensus revenue forecasts, allowing investors to assess the pace of business expansion and recognize the fading of bullish momentum before an actual decline in share prices.

Competing companies

Company Future Sales Volume DXCM (Dexcom)|NOVT (Novanta Inc) - Company Future Revenue|Projected Sales Volume HAE (haemonetics.com)|INSP - Company Future Sales Volume|PROCEPT BioRobotics Corp - Projected Sales Volume|Company Expected Sales Volume CONMED Corporation|PLSE: Projected Sales Volume|Company Revenue Forecast INMD|PMI (Picard Group) - Projected Sales Volume|Surmodics Corp (SRDX) - Company Future Sales|Projected Sales Volume SENS|Company Future Sales Volume NeuroPace, Inc. NPCE|Projected Sales Volume TCMD (Tactile Systems Technology, Inc.)|Projected Sales Volume SANUWAVE Health SNWV|outsetmedical.com - Projected Sales Volume|ELMD: Company Projected Revenue|LNSR (LENSAR, Inc.) - Company Future Sales Volume|AVITA Medical, Inc. - Company Future Revenue|PROF (Profound Medical Corp) - Projected Sales Volume|Company Expected Sales Volume bairdmed.com BDMD|Company Projected Revenue EDAP TMS (EDAP)|Bovie Medical (APYX) - Company Sales Forecast|IceCure Medical Ltd. - Company Future Sales Volume|Projected Sales Volume Pulmonx Corp. LUNG|TELA Bio Inc. - Projected Sales Volume|Company Future Sales CytoSorbents Corporation CTSO|Sensus Healthcare (SRTS) - Company Projected Revenue|Company Expected Revenue ZYXI (Zynex Corp)|Company Projected Revenue electrocore.com|Company Future Sales Volume Vicarious Surgical Inc. (RBOT)|Projected Sales Volume IINN|SeaStar Medical Holding Corp - Company Revenue Forecast|Company Projected Revenue iridex.com IRIX|INBS: Company Revenue Forecast|XAIR: Company Future Sales Volume|profusa.com - Company Projected Revenue Volume|STRATA Skin Sciences (SSKN) - Company Projected Revenue|Company Sales Forecast glucotrack.com GCTK|NAOV (nanovibronix.com) - Projected Sales Volume|Company Expected Sales Volume Venus Concept Corporation VERO|Company Future Sales Volume NUWE (nuwellis.com)|Company Projected Revenue Volume AEMD|Company Projected Revenue asensus.com ASXC|AVGR: Company Revenue Forecast|BioSig Technologies, Inc - Projected Sales Volume|Company Future Revenue CUTR (Cutera, Inc)|KNW: Projected Sales Volume|inarimedical.com - Company Future Revenue|NVRO (Nevro Corp) - Projected Sales Volume|Company Expected Sales Volume ReShape Lifesciences Inc. RSLS|Projected Sales Volume SILK